Description
DMRIE-C Reagent is suitable for the transfection of DNA (1,2) and RNA (3,4) into eukaryotic cells, and is particularly effective for transfection of suspension cells (e.g. Jurkat) and other lymphoid-derived cell lines. Refer t the Cell Lines database at www.invitrogen.com for a list of cell types successfully transfected. DMRIE-C can also be used for in vivo delivery of DNA (5). DMRIE-C is a 1:1 (M/M) liposome formulation of the cationic lipid DMRIE (1,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl ammonium bromide) (6) and cholesterol in membrane filtered water.
Important Guidelines for Transfection
- Form complexes using the amounts of DNA (or RNA) and DMRIE-C recommended. Optimize as necessary. Note: We recommend diluting DNA (or RNA) and DMRIE-C into Opti-MEM® I Reduced Serum Medium (Cat. No. 31985-062) before complexing.
- DMRIE-C is a lipid suspension that may settle with time. Mix thoroughly by inverting the tube 5-10 times before use.
- Transfect cells at the confluence or cell density recommended. Optimize as necessary. Maintain the same seeding conditions between experiments.
- Do not add antibiotics to media during transfection as this causes cell death.
- For optimal results, perform transfection in medium without serum. Cells may be transfected in the presence of serum, if desired; however, complexes must be formed in serum-free medium.
- Test serum-free media for compatibility with DMRIE-C since some serum-free formulations (e.g., CD 293, 293 SFM II, VP-SFM) may inhibit cationic lipid-mediated transfection.
- Procedures are provided to transfect cells in a 6-well format (60-mm format for stable transfection with DNA). For other formats, vary the amounts of DNA (or RNA), DMRIE-C, cells, and medium used in proportion to the relative surface area of the tissue culture vessel.
This product is distributed for laboratory research only. CAUTION: Not for diagnostic use. The safety and efficacy of this product in diagnostic or other clinical uses has not been established.
Use the following procedure to transiently or stably transfect DNA into mammalian cells. All amounts and volumes are given on a per well basis.
- One day before transfection, plate cells in growth medium without antibiotics such that they will be at the recommended confluence at the time of transfection.
Condition | Cell no. | Growth med. vol. | Format | Confluence at txfn |
---|
Transient | 1-2 x 105 | 2 ml | 6-well | 60-80% |
60-80% | 1-2 x 105 | 4 ml | 60-mm | 30-50% |
- For each transfection sample, prepare complexes as follows:
- a. Dilute 1-2 μg of DNA in 500 μl (1 ml for stable transfection) of Opti-MEM® I Reduced Serum Medium (or other medium) without serum.
- b. Mix DMRIE-C before use, then dilute 2-12 μl of DMRIE-C in 500 μl (1 ml for stable transfection) of Opti-MEM® I Medium (or other medium) without serum. Let stand at room temperature for 30-45 minutes.
- c. Combine the diluted DNA with diluted DMRIE-C (total volume = 1 ml; 2 ml for stable transfection). Mix gently and incubate for 15-45 minutes at room temperature (solution may appear cloudy).
- Remove the growth medium from the cells and wash once with 2 ml of= growth medium without serum. Remove the wash medium.
- Add the complexes (Step 2c) to cells. Mix gently by rocking the plate back and forth.
- Incubate cells at 37°C in a CO2 incubator for 4-24 hours.
- Replace the medium with 2 ml of growth medium containing serum (4 ml for stable transfection). Alternatively, add 1 ml of growth medium containing 2X the normal concentration of serum (2 ml for stable transfection) without removing the DNA-containing medium.
- Transient: Test for transgene expression 24-72 hours post-transfection. Stable cell lines: Passage cells at a 1:5 (or higher dilution) into selective medium 48-72 hours post-transfection.
Use the following procedure to transfect mammalian cells with RNA in a
6-well format. All amounts and volumes are given on a per well basis.
- One day before transfection, plate 2-3 x 105 cells in 2 ml of growth medium without antibiotics such that they will be 80% confluent at the time of transfection.
- Just before transfection, remove the growth medium from the cells and wash once with 2 ml of growth medium without serum. Remove wash medium. Proceed to Step 3.
- For each transfection sample, prepare complexes as follows:
- a. To a 12 x 75 mm polystyrene tube, add 1 ml of Opti-MEM® I Medium (or other medium) without serum. Mix DMRIE-C before use, then dilute 2-12 μl into the medium. Mix or vortex briefly.
- b. Add 2-5-5 μg of RNA into the tube containing DMRIE-C and medium (Step 3a). Mix or vortex briefly, then immediately add complexes to washed cells.
- Incubate at 37°C in a CO2 incubator for 4 hours, then replace transfection medium with complete growth medium.
- Assay for expression of transfected RNA 16-24 hours post-transfection. Note: Capped and polyadenylated mRNA is translated more efficiently and is more stable within the cell.
To obtain the highest transfection efficiency and low non-specific effects, optimize transfection conditions by varying cell density, DNA (or RNA) and DMRIE-C concentrations, and transfection incubation time.
DMRIE-C is tested for the absence of microbial contamination using blood agar plates, Sabouraud dextrose agar plates, and fluid thioglycolate medium, and functionally by transfection of Jurkat cells with a reporter plasmid. DMRIE-C is also tested for the absence of RNase activity using globin mRNA as a substrate.
1. Ciccarone, V., et al. (1995) Focus® 17, 84.
2. Macdonald, A.S., et al. (1996) Focus® 18, 6.
3. Ciccarone, V., et al. (1994) Focus® 16, 94.
4. Schifferli, K.P. and Ciccarone, V. (1996) Focus® 18,45.
5. Logan, J.J., et al. (1995) Gene Therapy 2, 38.
6. Felgner, J.H., et al. (1994) J. Biol. Chem. 269, 2550.